在患者的代谢和脂质组的变化与内置支架置症
Ziqi Xu1, Chenye Mou1, Renjie Ji1
1Department of Neurology, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
CNS neuroscience & therapeutics
|July 15, 2024
概括
静脉静脉缩 (ISR) 涉及到新陈代谢的改变,特别是在氨酸和氨酸途径中. 醇硫酸盐和酸糖胺 (38:4) 显示出作为生物标志物的承诺,用于识别ISR.
科学领域:
- 心血管研究研究心血管研究
- 代谢学 代谢学 代谢学
- 生物标志物发现发现
背景情况:
- 静脉静脉阻塞 (ISR) 阻碍了血液流动,可能导致中风.
- 内皮细胞的过度增殖和血栓形成是ISR的关键原因,改变了血管内代谢.
- 在ISR中发生的代谢变化仍然不太了解.
研究的目的:
- 为了描述ISR和非静脉缩 (NR) 患者之间的血清代谢组差异.
- 确定涉及ISR的关键代谢途径.
- 探索ISR检测的潜在生物标志物.
主要方法:
- 血清代谢和脂质组学分析.
- 在ISR和NR患者组之间的代谢资料的比较.
- 识别显著改变的代谢物和途径.
主要成果:
- 半氨酸和氨酸通路在ISR组中表现出增加的活性.
- 在ISR患者中,高水平的N-甲基-l-甲氨酸,L-甲氨酸,2-黄酸,Pyruvate和Taurocholate.
- 改变的脂质样本 (增加的酸丁胆和酸丁,减少的三糖醇),并确定了硫酸盐和PS{38:4}作为潜在的生物标志物 (AUC>0.85).
结论:
- 在ISR患者中存在显著的代谢变化.
- 氨酸和氨酸通路在ISR中受到显著影响.
- 硫酸盐和PS{38:4) 显示出作为ISR.38的诊断生物标志物的潜力.
更多相关视频
11:02Identification and Quantification of Deranged Metabolites in Critically Ill Patients Using NMR-Based Metabolomics
Published on: November 29, 2024
512
09:26Cellular Lipid Extraction for Targeted Stable Isotope Dilution Liquid Chromatography-Mass Spectrometry Analysis
Published on: November 17, 2011
16.1K
相关概念视频
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
628
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
628
Inflammation
53.3K
Overview
53.3K
